This issue of Bracco 1 deals with the subject of autoimmune thyroids. Some forms of a disease, the thyroid, are outlined in their most explicit and indicative clinical elements, a disease that is not frequent but not so rare that it does not deserve to be mentioned to the practising physician, who may encounter it in his professional activity.
Place of publication
Milano
Extent
Quantity:
2
Reference code
Reference code:
b. 1, fasc. 5
Structure
The autoimmune thyroids (p. 3-I)
de Quervain's thyroid (p. 6-I)
Contrast between signs of hyperthyroidism and abolished radioiodine thyrofixation (p. 6-I)
General and local signs of inflammation (p. 6-I)
Histologic picture (p. 8-I)
Inhibition of pituitary thyrotropin secretion (p. 9-I)
TSH stimulation test (p. 10-I)
Corticosteroid therapy (p. 10-I)
Prognosis (p. 10-I)
Thyroid antibodies (p. 10-I)
Hashimoto's thyroid (p. 10-I)
Segregated antigens (p. 10-I)
Tissue hypersensitivity (p. 14-I)
Hashimoto's goiter + hyperthyroidism (p. 15-I)
Positive perchlorate test (p. 15-I)
Very high thyroid antibodies (p. 15-I)
Carcinoma and Hashimoto's (p. 15-I)
Histology (p. 15-I)
Riedel's thyroid (p. 23-I)
Histology (p. 23-I)
Ligneous infiltrating goiter (p. 23-I)
Compressive symptoms (p. 23-I)
Surgical therapy (p. 23-I)
Technical features
24 p. (1-24 pp.) : ill. ; 34x16 cm
Notes
Editor-in-Chief: Tullio Bracco
Editor: Ketto Cattaneo
Layout: Mario Scheichenbauer
Drawings and graphics: Lido Picarelli
Printing: Amilcare Pizzi S.p.A.
Cover: Immunofluorescence reactions for thyroglobulin antigen on fixed thyroid section in a personal case of chronic Hashimoto's lymphomatous thyroid.
We would like to point out the advertising for Merck-Bracco pharmaceutical products featured in the issue: Encefabol, Lyspamin, Urovalidin and Dacortilen Merck.
Bi-monthly publication;
